세계 유방 고정술 시장 규모는 2024년 25억 2,000만 달러에서 2032년 40억 5,000만 달러에 달하고, 예측 기간인 2025-2032년 연평균 6.13% 성장할 것으로 예측됩니다. 바디 컨투어링과 노화 증상 치료를 위해 미용 시술을 찾는 사람들이 늘어나면서 시장은 큰 폭의 성장세를 보이고 있습니다. 유방 고정술은 자연 노화, 임신, 수유, 체중 감소로 인해 처진 유방을 들어올려 모양을 잡아주는 역할을 합니다. 소셜미디어의 영향력은 미의 기준의 변화와 함께 특히 30-50대 여성을 중심으로 유방 고정술을 선택하는 사람들을 늘리고 있습니다.
시장은 안전성과 결과를 향상시키는 첨단 임플란트 기술 및 회복기간 단축과 함께 최소침습 수술을 포함한 수술 기법의 향상으로 인해 긍정적인 영향을 받고 있습니다. 북미는 높은 의료비 지출과 숙련된 성형외과 의사가 다수 존재하고 연간 수술 건수가 많기 때문에 시장이 그 지위를 유지하고 있습니다. 아시아태평양은 가처분 소득 증가와 의료시설에 대한 접근성 향상과 함께 의료관광이 성장하고 있어 시장 확대를 가장 빠르게 주도할 것으로 보입니다.
유방 거상술과 유방 보형물을 포함한 복합 수술의 인기는 맞춤형 솔루션의 가용성과 함께 시장의 추가 환자 확보에 기여하고 있습니다. 유방 거상술 시장은 향후 몇 년 동안 이러한 시장 성장 촉진요인으로 인해 지속적으로 확대될 가능성이 높습니다.
예를 들어, 2025년 2월, Establishment Labs Holdings Inc.는 유방 미용 및 재건 수술을 통해 여성의 건강 및 웰빙을 향상시키는 데 주력하는 세계 의료 기술 기업입니다. 회사는 브라질에서 Preserve를 정식으로 도입하여 세계 제품 출시의 초기 단계에 접어들었습니다. 회사는 Establishment Labs의 Mia Femtech의 개발을 계속하고 있으며, Preserve라는 이름의 최소침습적 플랫폼을 통해 두 번째 제품을 출시했습니다.
세계의 유방 고정술 시장에 대해 조사 분석했으며, 시장 규모와 예측, 시장 역학, 주요 기업 개요 등의 정보를 전해드립니다.
Global mastopexy market is projected to witness a CAGR of 6.13% during the forecast period 2025-2032, growing from USD 2.52 billion in 2024 to USD 4.05 billion in 2032. The global market for mastopexy is experiencing substantial growth as more people seek aesthetic treatments for body contouring and the treatment of aging symptoms. A breast lift operation called mastopexy serves to elevate and reshape drooping breasts, which results from natural aging, pregnancy, breastfeeding, and significant weight loss. Social media influence, alongside changing beauty standards, drives increasing numbers of people, particularly women between 30 to 50 years old, to select breast lift surgeries.
The market receives positive effects from surgical technique improvement, which include minimally invasive procedures alongside advanced implant technologies and faster recovery periods that improve safety and results. The market holds its position in North America because of substantial healthcare expenditures and numerous skilled cosmetic surgeons, together with a high number of annual procedures. The Asia-Pacific region will lead market expansion at the fastest rate because medical tourism grows alongside rising disposable income and improved access to aesthetic healthcare facilities.
The popularity of combination procedures, including mastopexy with augmentation, together with customized solution availability, helps the market reach additional patients. The mastopexy market shows strong potential for continued expansion throughout the upcoming years because of these market drivers.
For instance, in February 2025, Establishment Labs Holdings Inc. operates as a worldwide medical technology company that focuses on enhancing women's health and wellness through breast aesthetics and reconstruction procedures. The company officially introduced Preserve in Brazil, which marks the initial phase of its worldwide product expansion. The Company introduced its second product through the minimally invasive platform named Preserve, which continues the development of Mia Femtech by Establishment Labs.
Aesthetic and Anti-aging Trends Boost Global Mastopexy Market Demand
The global demand for mastopexy procedures experiences substantial growth because of aesthetic and anti-aging trends. The growing societal interest in youthful appearance, together with body image concerns, leads many individuals, primarily females, to undergo cosmetic surgery for physical aesthetic improvements. Breast lift surgery or mastopexy provides treatment for drooping breasts which occur from aging, weight fluctuations, and pregnancy effects, to restore youthful breast contours. Social media platforms joined with celebrity culture and beauty influences have normalized cosmetic procedures, which have increased public knowledge and acceptance. Growing aging population with rising disposable income chooses to spend money on procedures that eliminate visible aging signs. Mastopexy has become more attractive to potential patients because of the changing patient demographics and improved surgical methods, which require fewer incisions and shorter healing periods. The marketing approach from clinics positions these procedures within anti-aging packages to drive higher patient interest. Mastopexy procedures continue to experience steady growth because of current aesthetic trends and anti-aging developments.
Additionally, to maintain the trend, companies are collaborating despite advancements in breast cancer research and treatment. For instance, in October 2024, Galderma confirmed its ongoing partnership with the National Breast Cancer Foundation (NBCF) to support breast cancer survivors. The partnership continues its work to support individuals affected by breast cancer by providing services that enable survival and thriving. The partnership works to provide cutting-edge aesthetic solutions that enable individuals to rebuild their confidence and experience life with fresh energy.
Advancements in Surgical Techniques Fuel Market Growth
The mastopexy market benefits from surgical technique innovations, which drive its growth through better results alongside lower risk factors, and enhanced patient satisfaction. The current mastopexy operations rely on minimal surgical techniques alongside better incision designs and enhanced suturing systems to produce natural results which decrease scar visibility. Patients show rising interest in three main mastopexy market developments, which include laser-assisted lifts and 3D imaging pre-surgical planning, as well as combination procedures with mastopexy and augmentation. Internal bra techniques together with absorbable mesh implants offer extended duration of results, which minimizes the requirement for revision surgeries. The latest developments in mastopexy procedures have shortened recovery durations and reduced medical complications while improving operational effectiveness, which draws more patients and surgeons to choose this procedure. Clinics and manufacturers direct their investments toward new technologies because aesthetic standards continue to evolve while patients seek customized, safe effective procedures. These advancements serve as essential drivers for the rapid global expansion of the mastopexy market.
For instance, in September 2024, POLYTECH Health & Aesthetics GmbH introduced Opticon Plus as its newest product in its extensive product range. The new implant from POLYTECH extends their comprehensive product line by bridging the space between Replicon and Opticon anatomical forms. Surgeons now have access to Opticon Plus, which provides a base design that stands between the round Replicon base and the standard Opticon short oval base.
Breast Implants Hold the Largest Global Mastopexy Market Share
Breast implants maintain the highest market share within the mastopexy industry because patients increasingly choose dual procedures that address volume enhancement and breast position improvement. Patients who select breast lifts simultaneously pursue enhanced breast volume and youthful contours which implants deliver successfully. The combination of mastopexy with augmentation has gained popularity because it provides enduring aesthetic results that attract women who experience volume loss from aging and pregnancy and weight loss. The development of safer materials and diverse implant shapes and sizes, alongside more realistic outcomes, has boosted consumer confidence about implant technology. Plastic surgeons recommend implants during mastopexy procedures to achieve better symmetry and firmness which leads to more patients choosing this option. Beauty standards and customizable implant options together drive the preference for breast implants which maintain their position as the leading choice in the global mastopexy market.
For instance, in December 2024, Mentor Worldwide LLC, a part of Johnson & Johnson MedTech, revealed that the U.S. Food and Drug Administration (FDA) approved MENTOR MemoryGel Enhance Breast Implants for use in both primary and revision post-mastectomy breast reconstruction operations. The innovative silicone gel-filled implant collection provides an expanded selection of base widths together with new projections and volumes that extend to 930 cc through 1445 cc, the highest volume available in the market. The commercial debut of MemoryGel Enhance Breast Implants by Mentor occurs in the United States starting from mid-2025.
North America Dominates the Global Mastopexy Market Size
North America dominates the global mastopexy market due to several key factors such as high healthcare budgets, modern medical facilities, and a developed, strong public interest in cosmetic treatments. Aesthetic surgery rates in the United States rank among the highest worldwide because many women select mastopexy for breast sagging repair, which results from aging and weight changes and pregnancy effects. Market expansion receives significant support from the availability of skilled plastic surgeons and advanced surgical technologies, together with widespread public knowledge about aesthetic procedures. The market is expanding because of increasing disposable income levels and growing cultural support for cosmetic procedures. The region also gains from powerful social media trends and celebrity-driven beauty standards that motivate more people to pursue body contouring treatments. The rising focus on personal wellness and self-care practices has integrated mastopexy into broader anti-aging and lifestyle enhancement trends, which makes North America the leading market for this procedure.
Additionally, the rising cases of breast cancer support this region to grow in the mastopexy market. For instance, according to the American Cancer Society's estimates, about 316,950 new cases of invasive breast cancer will be diagnosed in women in 2025. Such growing cases increase the demand for mastopexy or breast lift surgery.
Impact of U.S. Tariffs on Global Mastopexy Market
U.S. tariffs have triggered substantial market shifts in mastopexy (breast lift) procedures because imported medical devices and materials have become more expensive. Surgical equipment, along with implants and related supplies, faces increased tariffs, which drive up prices for medical facilities and their patients, potentially leading to decreased demand. The rising costs might cause healthcare providers to explore domestic supply options or postpone non-urgent operations, thus affecting market growth rates. The increased expenses discourage businesses from launching operations in the aesthetic surgery market, which results in reduced innovation and fewer available services. The rising costs serve as a deterrent for patients who might otherwise undergo mastopexy treatments, which results in reduced procedure numbers. Domestic manufacturers experience an increased market share because consumers prefer local manufacturing products over imported materials. U.S. tariffs have generated financial uncertainties that affect pricing structures, as well as accessibility and market operations within the mastopexy industry.
Key Players Landscape and Outlook
The global mastopexy market competition involves major aesthetic corporations and clinical facilities that specialize in innovation alongside patient safety measures and satisfaction protocols. Main players direct their investments toward enhanced surgical procedures and implant technology alongside strategic alliances to broaden their worldwide presence. The market outlook remains optimistic because of increasing cosmetic treatment popularity, together with expanding medical tourism and shifting notions of beauty. The market will show consistent expansion while facing stronger competition due to ongoing technological progress throughout the next years.
In June 2023, the U.S. Food and Drug Administration (FDA) provided 510(k) clearance to Sientra, Inc. for its innovative AlloX2 Pro Tissue Expander. The AlloX2 Pro became the initial tissue expander in the United States to receive MRI-conditional approval, which permits its use during magnetic resonance imaging procedures needed by breast reconstruction patients.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.